Tobias Neff

3.5k total citations
64 papers, 2.5k citations indexed

About

Tobias Neff is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Tobias Neff has authored 64 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Hematology and 15 papers in Genetics. Recurrent topics in Tobias Neff's work include Virus-based gene therapy research (14 papers), Epigenetics and DNA Methylation (13 papers) and RNA Interference and Gene Delivery (11 papers). Tobias Neff is often cited by papers focused on Virus-based gene therapy research (14 papers), Epigenetics and DNA Methylation (13 papers) and RNA Interference and Gene Delivery (11 papers). Tobias Neff collaborates with scholars based in United States, Switzerland and Germany. Tobias Neff's co-authors include C. Anthony Blau, Scott A. Armstrong, Stuart H. Orkin, Hans‐Peter Kiem, Marc A. Kerenyi, Guoji Guo, Woojin Kim, Brian C. Beard, Laura J. Peterson and Loren D. Walensky and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Tobias Neff

61 papers receiving 2.5k citations

Peers

Countries citing papers authored by Tobias Neff

Since Specialization

Citations

This map shows the geographic impact of Tobias Neff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Neff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Neff more than expected).

Fields of papers citing papers by Tobias Neff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Neff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Neff. The network helps show where Tobias Neff may publish in the future.

Co-authorship network of co-authors of Tobias Neff

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Neff. A scholar is included among the top collaborators of Tobias Neff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Neff. Tobias Neff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma 2025 ·Annals of Oncology ·Ana Arance, Miguel‐Ángel Berciano‐Guerrero, Jun Guo, (unknown), Paolo A. Ascierto, Mauricio Burotto, Laurent Mortier, (unknown), Vanna Chiarion‐Sileni, Jacob Schachter, Xiang Zhang, (unknown), M. Del Vecchio, Chinyere E. Okpara, Corina E. Dutcus, Jie Zhang, Scott J. Diede, Tobias Neff, Georgina V. Long	0
2	Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors 2023 ·British Journal of Cancer ·Anthony B. El-Khoueiry, James S. Clarke, Tobias Neff, (unknown), (unknown), Chetan Rathi, (unknown), (unknown), Ignacio Garrido‐Laguna, Emiliano Calvo, Jordi Rodón, Ben Tran, Peter J. O’Dwyer, Adam Cuker, Albiruni R. Abdul Razak	46
3	Epigenetic regulation of protein translation in KMT2A-rearranged AML 2020 ·Experimental Hematology ·(unknown), Hongbo Xie, (unknown), (unknown), (unknown), (unknown), Simone S. Riedel, Zuo‐Fei Yuan, Nan Zhu, Tobias Neff, Kathrin M. Bernt	8
4	Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations 2018 ·PLoS Genetics ·Matthew R. Hart, Donovan J. Anderson, Christopher C. Porter, Tobias Neff, Michael Levin, Marshall S. Horwitz	4
5	MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia 2017 ·Cancer Cell ·Yufei Chen, Konstantinos Anastassiadis, Andrea Kranz, Aengus Stewart, (unknown), Claudia Waskow, Akihiko Yokoyama, Kenneth L. Jones, Tobias Neff, (unknown), Patricia Ernst	65
6	The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities 2016 ·Frontiers in Pediatrics ·Kathrin M. Bernt, Stephen P. Hunger, Tobias Neff	9
7	Histone profiles in cancer 2015 ·Pharmacology & Therapeutics ·Simone S. Riedel, Tobias Neff, Kathrin M. Bernt	5
8	Mapping Cellular Hierarchy by Single-Cell Analysis of the Cell Surface Repertoire 2013 ·Cell stem cell ·Guoji Guo, Sidinh Luc, Eugenio Marco, (unknown), Cong Peng, Marc A. Kerenyi, Semir Beyaz, Woojin Kim, Jian Xu, Partha Pratim Das, Tobias Neff, Keyong Zou, Guo‐Cheng Yuan, Stuart H. Orkin	175
9	Chromatin maps, histone modifications and leukemia 2009 ·Leukemia ·Tobias Neff, Scott A. Armstrong	37
10	Postconditioning with a volatile anaesthetic in alveolar epithelial cellsin vitro 2007 ·European Respiratory Journal ·Tianli Yue, Birgit Roth Z’graggen, S. Blumenthal, Simona B. Neff, Livia Reyes, Christa Booy, Marc P. Steurer, D. R. Spahn, Tobias Neff, Edith R. Schmid, Beatrice Beck‐Schimmer	44
11	Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates 2007 ·Experimental Hematology ·Chul Won Jung, Brian C. Beard, Julia Morris, Tobias Neff, Katherine Beebe, Barry E. Storer, Hans‐Peter Kiem	8
12	Stem cell gene transfer—efficacy and safety in large animal studies 2004 ·Molecular Therapy ·Peter A. Horn, Julia Morris, Tobias Neff, Hans‐Peter Kiem	24
13	Accurate continuous drug delivery at low infusion rate with a novel microvolumetric infusion pump (MVIP): pump design, evaluation and comparison to the current standard 2004 ·Anaesthesia ·(unknown), Simon Gerber, Rudolf Marcel Füchslin, Tobias Neff	17
14	Warming of infusion syringes caused by electronic syringe pumps 2003 ·Acta Anaesthesiologica Scandinavica ·(unknown), B Frey, Tobias Neff, Andreas Gerber, M Weiss	1
15	Pharmacologically regulated in vivo selection in a large animal 2002 ·Blood ·Tobias Neff	69
16	Always flush the sampling port before flushing the arterial cannula in pediatric patients 2001 ·Acta Anaesthesiologica Scandinavica ·(unknown), Joachim E. Fischer, Tobias Neff, Maja I. Hug, O. Baenziger	2
17	Start‐up delays of infusion syringe pumps 2001 ·Pediatric Anesthesia ·Tobias Neff, Joachim E. Fischer, (unknown), O. Baenziger, (unknown)	60
18	Auswirkungen von Luftbläschen in der Infusionsspritze auf die Funktion von Spritzenpumpen 2000 ·Der Anaesthesist ·Gabriele Schulz, Joachim E. Fischer, Tobias Neff, (unknown), M Weiss	15
19	Stem cell gene therapy, position effects and chromatin insulators 1997 ·Stem Cells ·Frank Shotkoski, (unknown), Tobias Neff	30
20	The Hematological Effects of Folate Analogs: Implications for Using the Dihydrofolate Reductase Gene for In Vivo Selection 1996 ·Human Gene Therapy ·C. Anthony Blau, Tobias Neff, Thalia Papayannopoulou	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact